|
|
|
|
|
by Slimbo
1917 days ago
|
|
My very basic understanding is you customise the mRNA payload towards the immune system targetting the mutating cells that have caused cancer in a patient (after the cancer material has been surgically removed). This prevents the cancer from re-occuring. |
|